Daily Bulletin (28th November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191128-31

1.Scrip code : 531212
Name : Nalin Lease Finance Ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
With regards to the captioned matter, we would like to inform you that the Hon”ble National Company Law Tribunal, Ahmedabad Bench (‘NCLT”) has sanctioned the Scheme of Arrangement involving Amalgamation of Amee Finance Limited, Gandhi Shroff Services Private Limited, Nalin Services Limited and Nalin Consultancy Services Limited with Nalin Lease Finance Limited (‘Scheme’) under Sections 230 to 232 of the Companies Act, 2013 and other applicable provisions of the Act and the Rules framed thereunder. The copy of NCLT Order sanctioning the Scheme, as uploaded and available on the website of the NCLT, is attached herewith for your reference and record. The Scheme will become effective upon filing of the certified copy of Order of the NCLT sanctioning the Scheme with the Registrar of Companies, Ahmedabad. The same will be intimated to the Stock Exchange in due course.

2.Scrip code : 524804
Name : Aurobindo Pharma Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that Auro Vaccines LLC, 100% subsidiary of Aurobindo Pharma USA Inc., USA, which in turn is 100% subsidiary of the Company, has entered into a definitive agreement to acquire certain business assets from Profectus BioSciences Inc., USA., a clinical-stage vaccine development company. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’.

3.Scrip code : 500087
Name : Cipla Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Cipla Limited”s wholly owned subsidiary Cipla (EU) Limited, holding 60% stake in Cipla Pharma Lanka (Private) Limited {Cipla Pharma Lanka), Sri Lanka, has signed an agreement with CitiHealth Imports(Private) Limited to acquire the remaining 40% stake in Cipla Pharma Lanka. Post-acquisition, Cipla Pharma Lanka will become a wholly owned subsidiary.

4.Scrip code : 500325
Name : Reliance Industries Ltd
Subject : Announcement under Regulation 30 (LODR)-Acquisition
This is in furtherance to the disclosure made by the Company on October 25, 2019 with respect to setting up a wholly-owned subsidiary (WOS) for Digital Platform initiatives. It is hereby informed that the WOS has been incorporated and the Company, as a subscriber to the memorandum of association of the WOS, has invested Rs 1,00,000 to acquire 10,000 equity shares of Rs. 10 each at par of the WOS namely ‘Jio Platforms Limited’ (JPL). JPL was incorporated on November 15, 2019 and is yet to commence its business operations. The investment in JPL does not fall within related party transaction and the promoter/ promoter group/ group companies do not have any interest in JPL. No governmental or regulatory approvals were required for the said investment.

Daily Bulletin (7th November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191107-22

1.Scrip code : 524324
Name : Seya Industries Ltd
Subject : Board Meeting Intimation for Board Meeting Is Scheduled To Be Held On November 22, 2019 To Consider Sub Division Of Shares Of The Company
SEYA INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2019 ,inter alia, to consider and approve Board Meeting is scheduled to be held on November 22, 2019 to consider Sub division of Shares of the Company

2.Scrip code : 522215
Name : Swiss Glasscoat Equipments Ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation related to sanction given by the Hon’ble National Company Law Tribunal, Ahmedabad Bench (‘NCLT’) with regards to the Composite Scheme of Arrangement involving Demerger and Transfer of the Operating Business of HLE Engineers Private Limited to Swiss Glascoat Equipments Limited and Amalgamation of Yashashvi Agrochemical Private Limited with HLE Engineers Private Limited and their respective Shareholders and Creditors (‘Scheme’) under Sections 230 to 232 read with Section 66 of the Companies Act, 2013 and other applicable provisions of the Act and the Rules framed thereunder.

3.Scrip code : 532777
Name : Info Edge(India) Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. This is to inform you that the Company has entered into an agreement to invest about Rs. 21 Cr., in Metis Eduventures Private Limited (‘Adda247’) as primary acquisition of shares.

HUL-GSK Merger

HUL-GSK Merger

 

GSK
Company FV CMP 52week High 52week Low Mkt Cap Equity Capital Net Worth Total Debt Total Sales PAT BV EPS P/E P/BV Promoter’s Holdings
Rs Rs Rs Rs Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Rs %
2020 Q1 10 9229 9387.70 6842.05 38815 42 4343 0 1321 248 1032.52 58.98 39.12 8.94 72.46
2019 10 9229 42 4095 0 5215 983 973.54 233.67 39.50 9.48 72.46
HUL
Company FV CMP 52week High 52week Low Mkt Cap Equity Capital Net Worth Total Debt Total Sales PAT BV EPS P/E P/BV Promoter’s Holdings
Rs Rs Rs Rs Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Rs %
2020 H1 1 2138 2187.00 1629.00 462750 216 8058 79 20732 3613 37.31 16.73 63.90 57.31 67.18
2019 1 2138 216 7885 99 39860 6050 36.50 28.01 76.32 58.56 67.19

 

On December 3, 2018, FMCG giant Unilever had announced the acquisition of health food portfolio, including popular brands Horlicks and Boost, from GlaxoSmithKline in India and over 20 other markets for 3.1 billion pounds.

Under the deal, Unilever’s Indian arm, HUL would acquire GSK CH India via an all-equity merger, valuing the total business of the latter at Rs 31,700 crore.

The acquisition is said to be in line with the Hindustan Unilever strategy to build a sustainable and profitable Foods and Refreshment (F&R) business in India by leveraging the mega trend of health and wellness. GSK CH India is the market leader in the HFD category This portfolio has a long history in India with Horlicks having originally been introduced in the 1930s. Horlicks products have been an everyday staple in households across generations.

HUL is the number 1 FMCG business in the country with a demonstrated track record of delivering growth which is competitive, profitable, sustainable and responsible. Business has delivered growth of 10% CAGR in the last 10 years with EBIT improved by 5.3%.

According to Sanjiv Mehta, Chairman and Managing Director of HUL, “With this proposed strategic merger with GSK CH India, we will be expanding our portfolio with great brands into a new category catering to the nutritional needs of our consumers. I am confident that this merger will create significant shareholder value through both revenue growth and cost synergies. The turnover of our F&R business will exceed Rs.100 bn and we will become one of the largest F&R businesses in the country. We look forward to welcoming new brands and great talent into the Unilever and HUL family, once the transaction is complete.”

The merger of GSK CH India with HUL will be on a basis of an exchange ratio of 4.39 HUL shares for 1 GSK CH India Share, implying a total equity value of INR 317 bln for 100% of GSK CH India. Following the issue of new HUL shares, Unilever‘s holding in HUL will be diluted from 67.2% to 61.9%.

The merger includes the totality of operations within GSK CH India, including a consignment selling contract to distribute GSK CH India’s Over-the-Counter and Oral Health products in India.

On 6th Novemeber, 2019, HUL notified BSE and NSE saying that the NCLT Mumbai bench had sanctioned the aforesaid scheme and now the order was subject to be sanctioned by the NCLT Chandigarh Bench.

 

Daily Bulletin (6th November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191106-37

1.Scrip code : 542285
Name : Axita Cotton Limited
Subject : Board to consider Bonus Issue
With reference to the earlier letter dated November 04, 2019 regarding a meeting of the Board of Directors of the Company will be held on November 14, 2019 inter alia, to consider and approve the Unaudited Financial Results of the Company for the half year ended on September 30, 2019, to appoint internal auditor of the Company for the F.-Y. 2019-20 due to resignation of earlier internal auditor of the Company and to consider other business items, Axita Cotton Ltd has now informed BSE that in the aforesaid board meeting will be held on November 14, 2019, the Board of Directors of the Company will also consider the proposal for issue of Bonus Shares.

2.Scrip code : 500696
Name : Hindustan Unilever Ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
This is with reference to your observation letter bearing reference no. DCS/AMAL/JR/R37/1404/2018-19 dated 15th February, 2019 regarding the Scheme of Amalgamation by way of merger by absorption among GlaxoSmithKline Consumer Healthcare Limited (‘Transferor Company’) and Hindustan Unilever Limited (the ‘Company’) and their respective Shareholders and Creditors (the ‘Scheme’). We wish to inform you that the Hon’ble National Company Law Tribunal, Mumbai Bench, vide its order dated 24th September, 2019 (‘Order’), has sanctioned the aforesaid Scheme. This Order is subject to sanction of the Scheme by the Hon’ble National Company Law Tribunal, Chandigarh Bench. The certified copy of the aforesaid Order along with the sanctioned Scheme, as received by the Company on 6th November, 2019 from the Hon’ble National Company Law Tribunal, Mumbai Bench, is enclosed for your records.

3.Scrip code : 500800
Name : Tata Global Beverages Limited
Subject : Announcement under Regulation 30 (LODR)-Meeting Updates
Outcome of the National Company Law Tribunal, Kolkata Bench (‘Tribunal’) convened Meeting of the Equity Shareholders of Tata Global Beverages Limited (‘the Company’) held on Monday, November 04, 2019 This is to inform you that as per an Order dated September 20, 2019 passed by the Hon”ble National Company Law Tribunal, Kolkata Bench, a Meeting of the equity shareholders of the Company was convened i.e. on November 04, 2019 at 11.00 a.m. at Kala Mandir, 48, Shakespeare Sarani, Kolkata 700017 (”Meeting”), to consider, and if thought fit, to approve, with or without modification(s), the proposed Scheme of Arrangement between Tata Chemicals Limited (Demerged Company) and Tata Global Beverages Limited (Resulting Company) and their respective shareholders and creditors for the demerger of the Consumer Products Business of the Demerged Company to the Resulting Company (“Scheme”).

4.Scrip code : 535789
Name : INDIABULLS HOUSING FINANCE LIMITED
Subject : Outcome of Board Meeting
Enclosed are the Unaudited Standalone & Consolidated Financial Results of the Company for quarter and half year ended 30.09.2019, approved by its Board at its today’s meeting, commenced at 3:30 PM and concluded at 4:40 PM, along with Limited Review Reports, issued by Statutory Auditors. Board also declared an Interim Dividend of INR 7/- per equity share for FY19-20 (Record date – 19.11.2019). Further, the Board of Directors in the aforesaid meeting has also approved the issuance of secured and/or unsecured redeemable Non-Convertible Debentures of upto INR 10,000 Crore and Non-Convertible Debentures along with warrants through QIP of upto USD 1 billion, subject to applicable approvals. For further details pls. refer attached PDF file.

5.Scrip code : 540530
Name : Housing &Urban Development Corporation Ltd.
Subject : Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) For Quarter & Half Year Ended 30Th September, 2019.
Housing And Urban Development Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve The Unaudited Financial Results (Standalone and Consolidated) for quarter & half year ended 30th September, 2019. Intimation is hereby given pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended thereto and Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated persons and their immediate relatives and for Fair Disclosure of HUDCO, the Trading Window, for dealing in the securities of the Company, is already closed from Tuesday, the 1st October, 2019 till 48 hours after the declaration of financial results for the quarter & half-year ended 30th September, 2019, for which the intimation has already been given to Stock Exchange(s) vide letter no. HUDCO/CS/SE/2019 dated 18th September, 2019 and the same will re-open on Saturday, 16th November, 2019

Daily Bulletin (5th November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191105-32

1.Scrip code : 532756
Name : Mahindra CIE Automotive Limited
Subject : Corporate Action-Updates on Amalgamation/ Merger / Demerger
We refer to our letter dated 4th September, 2019 whereby we had inter-alia informed that petition seeking approval of the Hon’ble National Company Law Tribunal, Mumbai Bench (the Hon’ble Tribunal) to the Scheme of Merger by absorption of Bill Forge Private Limited (the Wholly owned subsidiary of the Company) by the Company (the Scheme) was kept for final hearing on 20th September, 2019. We now wish to inform you that after the hearing held on 20th September, 2019 and the Hon’ble Tribunal had reserved the same for Order. The Order approving the Scheme was delivered by the Hon’ble Tribunal on 4th November, 2019 and the minutes of the order is now available on the website of the Hon”ble Tribunal. Accordingly, the Scheme will be operational once the certified copy of the Order along-with the Scheme is filed with the Registrar of Companies, Mumbai. Kindly acknowledge the receipt and take the same on record.

2.Scrip code : 501455
Name : Greaves Cotton Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company has given an in-principle approval with respect to the acquisition of 18.77% stake in one its subsidiary companies i.e. Ampere Vehicles Private Limited, India (“Ampere”) through secondary purchase for a total consideration not exceeding Rs. 60 crores (including commitment fees and non-compete fees not exceeding Rs. 20 crores), subject to execution of the definitive agreements and customary closing conditions. Pursuant to the completion of the aforesaid acquisition, Ampere will become a wholly owned subsidiary of the Company.

3.Scrip code : 500338
Name : PRISM JOHNSON LIMITED.
Subject : Updates – Intimation Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBl (Listing Obligations & Disclosure Requirements) Regulations, 2015
we wish to inform you that the Company has agreed to acquire 15,00,000 equity shares at a price of of Rs. 35/- each aggregating to Rs. 5.25 Crores constituting 15% in the total paid-up equity share capital of Sanskar Ceramics Private Limited. The details required under Regulation 30 of SEBl (Listing Obligations & Disclosure Requirements) Regulations, 2015 are given as an annexure. We request you to kindly note and take the above information on record.

4.Scrip code : 532755
Name : Tech Mahindra Limited
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Approval of proposal for acquisition of Born Group Pte Ltd

5.Scrip code : 532754
Name : GMR Infrastructure Limited
Subject : Board Meeting Intimation for Consideration And Approving The Un-Audited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2019
GMR INFRASTRUCTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve un-audited financial results of the Company (Standalone and Consolidated) for The quarter and half year ended September 30, 2019.

Daily Bulletin (4th November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191104-19

1.Scrip code : 521064
Name : Trident Ltd
Subject : Corporate Action-Fixes Record Date For Split/ Sub-Division Of Equity Shares
The Register of Member and Share Transfer Books of the Company will be closed on Monday, the 16th day of December, 2019 for determining eligibility of shareholders for split/ sub-division of Equity Shares having existing nominal value of INR 10/- each into nominal value of INR 1/- each.

2.Scrip code : 540678
Name : Cochin Shipyard Limited
Subject : Announcement under Regulation 30 (LODR)-Updates on Acquisition
We would like to inform you that Cochin Shipyard Limited (CSL) has acquired 57,20,000 (26%) equity shares of Hooghly Cochin Shipyard Limited (HCSL), an unlisted subsidiary of CSL, held by Hooghly Dock & Port Engineers Limited (HDPEL) on November 01, 2019 at total consideration of Rs.5.06 crores. Prior to this acquisition of shares, CSL was holding 74% of the equity shares of HCSL. With this acquisition of shares, HCSL has become a Wholly Owned Subsidiary of CSL with a paid up share capital of Rs.22 crores.

3.Scrip code : 541974
Name : Manorama Industries Limited
Subject : Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (Hereinafter Referred To As ‘SEBI Listing Regulations’)
Manorama Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2019 ,inter alia, to consider and approve With reference to the captioned subject, we hereby inform you that the Meeting of the Board of Directors of Manorama Industries Limited will be held on Saturday, November 9, 2019 at 3.00 P.M. at F-6, Anupam Nagar, Raipur – 492007, Chhattisgarh to consider and approve, inter alia: 1. Standalone Unaudited Financial Results for the half year ended September 30, 2019 pursuant to Regulation 33 of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. 2. Any other business with the permission of the Chair. Kindly take the above on your records and acknowledge.

4.Scrip code : 503169
Name : Ruby Mills Ltd.
Subject : Board Meeting Intimation for Intimation Of Board Meeting To Consider _And Approve Un-Audited Financial Results And Limited Review Report There On For The Quarter And Half Year Ended September 30, 2019.
RUBY MILLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve In compliance with Regulation 29 of the Securities Exchange and Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that Meeting of Board of Directors of the Company is scheduled to be held on November 11,2019 (Monday) at 5.00 PM,inter alia, to consider and approve Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2019. We further inform you that, the trading window for dealing in securities of the Company is already being closed and the intimation of the same is given to BSE and NSE by the Company and shall remain closed till 48 hours after the declaration of Un-audited Financial Results with Limited Review Report there on for the quarter and half year ended September 30, 2019 in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015.

Daily Bulletin (1st November, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191101-32

 

1.Scrip code : 500108
Name : Mahanagar Telephone Nigam Ltd.
Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dear Sir, We write to inform you that MTNL has received letter No. F.No. 30-04/2019-PSU Affairs dtd 29 October, 2019 (copy enclosed) regarding Revival of BSNL and MTNL by reducing employee costs, administrative allotment of spectrum for 4G services, debt restructuring by raising of sovereign guarantee bonds, monetization of assets and in-principle approval for merger of BSNL and MTNL. Kindly take the same on record. This issues with the approval of Competent Authority.

2.Scrip code : 539981
Name : Max India Ltd.
Subject : Voting Results Of The Business Transacted At The National Company Law Tribunal Convened Meeting Of Equity Shareholders Of Max India Limited (“The Company”) Held On Wednesday, October 30, 2019 In Terms Of (I) Companies Act, 2013 And NCLT Order And (Ii) Pursuant To Securities Exchange Board Of India Circular No. CFD/Dll3/CIR/2017/21 Dated March 10.2017 (SEBI Circular)
Further to our earlier intimation dated October 31, 2019 with regard to submission of proceedings of meeting of Equity shareholders of the Company held on October 30, 2019, we hereby submit the Voting Results of the said meeting convened and held as per the directions of the Hon’ble National Company Law Tribunal, Mumbai Bench, for approving the Composite Scheme of Amalgamation and Arrangement amongst Max India Limited, Max Healthcare Institute Limited, Radiant Life Care Private Limited and Advaita Allied Health Services Limited and their respective shareholders and creditors under Sections 230 to 232 of the Companies Act, 2013 (‘Scheme’).

3.Scrip code : 524572
Name : Pharmaids Pharmaceuticals Ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
This is in continuation to our earlier communication regarding receipt of approval of National Company Law Tribunal, Hyderabad (NCLT) vide their order dated September 27, 2019 for the Scheme of Amalgamation between Emergent Bio Naturals Limited (Transferor Company) and Pharmaids Pharmaceuticals Limited (Transferee Company) We wish to inform you that pursuant to the said order and in accordance with the scheme of amalgamation, for every 1 (one) equity share of face and paid up value of Rs. 10/- each held in the transferor Company, 2 (two) equity shares of face and paid up value of Rs. 10/- in the Transferee Company will be issued to the equity shareholders of Transferor Company. Necessary filings for allotment of these shares will be filed with the stock exchanges and the depositories in due course of time.

4.Scrip code : 540975
Name : Aster DM Healthcare Limited
Subject : Announcement under Regulation 30 (LODR)-Acquisition With reference to the captioned subject, we would like to inform that Aster DM Healthcare FZC (step-down subsidiary of Aster DM Healthcare Limited), has incorporated a Limited Liability Company, Aster Alfaone FZ LLC, in Dubai. The details required as per Circular Number CIR/CFD/CMD/4/2015 dated September 09, 2015 pertaining to continuous disclosure requirements for Listed Entities under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, has been enclosed as Annexure I. We request you to kindly take the above information on record.

5.Scrip code : 509480
Name : Berger Paints India Ltd
Subject : Announcement under Regulation 30 (LODR)-Updates on Acquisition
Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 dated 15th October, 2019 and our letter dated 18th October, 2019, copies of which are attached for your ready reference, we would like to inform you that the Company has till now acquired 91.94 % of the paid-up equity share capital of STP Limited out of 95.53% to be acquired by the Company. The balance 3.59% of the paid-up equity share capital is intended to be acquired shortly, as per the Share Purchase Agreement entered between the parties. STP Limited has thus become a subsidiary of Berger Paints India Limited with effect from 1st November, 2019. A Press Release, which is being issued in this regard, is enclosed.

6.Scrip code : 500338
Name : PRISM JOHNSON LIMITED.
Subject : Updates – Intimation Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations
Pursuant to Regulation 30 of SEBl (Listing Obligations & Disclosure Requirements) Regulations, 2015 and further to our letter dated July 30, 2019, we wish to inform you that the Company has acquired 14,78,412 equity shares of ` 10/- each aggregating to ` 1,47,84,120 constituting 27% in the total paid-up equity share capital of Sunspring Solar Private Limited, a subsidiary of Cleantech Solar Energy (India) Private Limited, for the power requirement of the Company’s tiles manufacturing facilities aggregating up to 4.62 MWp for the said facilities. The solar power plants are expected to be commissioned by March 2020 in a phased manner.

PVR Ltd.

PVR Ltd.

PVR  Ltd.
Year FV CMP 52week High 52week Low Mkt Cap Equity Capital Net Worth Total Debt Total Sales PAT BV EPS P/E P/BV Promoter’s Holdings
  Rs Rs Rs Rs Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Rs     %
2020 Q2 10 1788.45 1897.95 1345.80 9173 48 1040 1226 1867 65 214.90 13.48 66.35 8.32 19.57
2019 10 1788.45       47 1496 1104 3119 183 320.00 39.21 45.61 5.59 20.25

CMP:- 1788.45

Market Cap:- 9173

The world’s largest sovereign wealth fund, Norway’s Government Pension Fund Global which manages $1 trillion of the country’s assets and the Kuwait Investment Authority with assets exceeding $590 billion are amongst top global investors who have subscribed to the qualified institutional placement of  PVR, the nation’s largest multiplex operator.

“The company’s total stake dilution via the QIP is 5.65 percent and the company has raised Rs 500 crore. The proceeds will be used for paring debt and increasing the screen count,” said a source familiar with the company’s plans.

“Kuwait Investment Authority has picked up the highest stake followed by Aditya Birla Sun Life Trustee Private Ltd, ICICI Prudential & Sundaram Mutual Fund. Morgan Stanley India Investment Fund, Government Pension Fund Global and Fidelity Funds – India Focus Fund are the other key investors. USA’S third-largest public pension plan New York State Common Retirement Fund, City of New York Group Trust and City of Los Angeles Fire and Police Pension Plan also participated in the process through their contribution was relatively much smaller,” said another source.

“The varied participation of global funds reflects their belief in the PVR growth story. Funds from Norway and the US are now closely looking at the consumer theme in India and may participate more in future,” added a third source.

The fundraising exercise was launched on October 22 and the allotment of investors was completed earlier this week on October 29. The issue price was fixed at Rs 1,719.05 a share. Investment banks Kotak Mahindra Capital and CLSA along with law firm Shardul Amarchand Mangaldas were advisors to PVR for the QIP.

In August 2019, PVR became the first cinema exhibitor to reach 800 screens at 170 properties in 69 cities.  In Q2FY20, PVR saw a 16 percent growth in advertising revenue which increased to Rs 94 crore, up from Rs 81 crore in Q2 in 2018 despite the economic slowdown. Along with the growth in advertising revenue, the box office revenue for the quarter was up by 32 percent led by a 25 percent growth in admits. Plus, F&B (food and beverage) revenues were up by 38 percent.

Daily Bulletin (30th October, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191030-30

1.Scrip code : 500020
1Name : Bombay Dyeing & Mfg. Co. Ltd.
Subject : Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended 30Th September, 2019.
BOMBAY DYEING & MFG.CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI (LODR) Regulations, 2015’), this is to notify that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 11th Page 41 bu301019 November, 2019 to inter alia consider and approve the unaudited financial results of the Company for the second quarter and half year ended 30th September, 2019. Further, as required in terms of Regulation 47 of the SEBI (LODR) Regulations, 2015, a public notice about the date of the aforesaid Board Meeting is also simultaneously being issued in the newspapers.

2.Scrip code : 542752
Name : Affle (India) Limited
Subject : Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2019
Affle (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2019 ,inter alia, to consider and approve Consideration and approval of unaudited standalone and consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019.

3.Scrip code : 532483
Name : Canara Bank
Subject : Canara Bank- Issue Of Equity Shares To GOI On Preferential Basis
In Continuation to our letter no MD&CEO:SD:751/752/11/12::2019 dated 24.10.2019 to the Stock Exchanges with regard to Postal Ballot Notice, we herewith provide the following disclosures in compliance with SEBI ICDR Regulations, 2018 1. The Bank proposes to issue/allot 27,69,88,576 equity shares of Rs 10 each at an issue price of Rs. 237.23 per equity share (including premium of Rs. 227.23 per share) in respect of Preferential Issue of shares to Government of India, the promoters of the Bank, against their capital contribution aggregating to Rs.6571 crore by way of special Resolution

4.Scrip code : 532689
Name : PVR Ltd.
Subject : Qualified Institutions Placement (‘QIP’ Or ‘Issue’) Of Equity Shares Of Face Value Of ? 10 Each (The ‘Equity Shares’) To Qualified Institutional Buyers (‘Qibs’)
We wish to inform you that in respect of the QIP, the Fund Raise Committee of the Company has, at its meeting today approved and adopted the placement document dated October 29, 2019 in connection with the QIP. The QIP was opened on October 23, 2019 and the same was intimated to you pursuant to our letter on same date. We request you to take the above on record pursuant to compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.We wish to inform you that the Fund Raise Committee of the Company at its meeting held today, i.e. 30th October, 2019, approved the issue and allotment of 29,08,583 Equity Shares to eligible QIBs at the issue price of ? 1,719.05 per Equity Share (including a premium of ? 1,709.05 per Equity Share) aggregating c. ? 50,000 Lakhs. Pursuant to the allotment of Equity Shares under the QIP, the paid-up equity share capital of the Company stands increased to ? 51,29,08,450 comprising of 5,12,90,845 Equity Shares of face value of ? 10/- each. The Issue opened on 23rd October, 2019 and closed on 29th October, 2019. The same was intimated to you vide letters dated 23rd October, 2019 and 29th October, 2019, respectively.

Daily Bulletin (29th October, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191029-38

1.Scrip code : 542446
Name : Jonjua Overseas Limited
Subject : Press Release.
Jonjua Air Private Limited has declared bonus in the ratio of 9:42. Jonjua Overseas Limited which is a shareholder of Jonjua Air Private Limited will be entitled to bonus shares on its holding.

2.Scrip code : 524804
Name : Aurobindo Pharma Ltd.
Subject : Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Notice dated 18.10.2019 of the NCLT convened Meeting of the Unsecured Creditors of the Company to be held on Saturday, November 30, 2019 at 2.00 P.M, as directed by Hon”ble NCLT, Hyderabad Bench, vide its order dt September 30, 2019 at KLN Prasad Auditorium, 3rd Floor, The Federation of Telangana Chamber of Commerce and Industry (FTCCI), Federation House, 11-6-841, FAPCCI Marg, Red Hills Hyderabad-500004, Telangana, for the purpose of considering and if thought fit, approving the Scheme of Amalgamation of APL Research Centre Limited (Transferor Company 1) and Aurozymes Limited (Transferor Company 2) and Curepro Parenterals Limited (Transferor Company 3) and Hyacinths Pharma Private Limited (Transferor Company 4) and Silicon Life Sciences Private Limited (Transferor Company 5) and APL Healthcare Limited (Transferor Company 6) with Aurobindo Pharma Limited (Transferee Company).

3.Scrip code : 539141
Name : UFO Moviez India Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Update on the Composite Scheme of Arrangement and Amalgamation amongst UFO Moviez India Limited (‘Company’), Qube Cinema Technologies Private Limited, Qube Digital Cinema Private Limited, Moviebuff Private Limited, PJSA Technosoft Private Limited (‘PJSA’) and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (‘Scheme’).